1
|
Hennon TR, Yu KOA, Penque MD, Abdul-Aziz R, Chang AC, McGreevy MB, Pastore JV, Prout AJ, Schaefer BA, Alibrahim OS, Gomez-Duarte OG, Hicar MD. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves. Prog Pediatr Cardiol 2021; 62:101407. [PMID: 34121829 PMCID: PMC8179839 DOI: 10.1016/j.ppedcard.2021.101407] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2021] [Accepted: 06/02/2021] [Indexed: 02/06/2023]
Abstract
Multisystem inflammatory syndrome of children (MIS-C) continues to be a highly concerning diagnosis in those recently infected with SARS-CoV-2. The diagnosis of MIS-C cases will likely become even more challenging as vaccine uptake and natural immunity in previously infected persons leads to lower circulating rates of SARS-CoV-2 infection and will make cases sporadic. Febrile children presenting with cardiac dysfunction, symptoms overlapping Kawasaki disease or significant gastrointestinal complaints warrant a thorough screen in emergency departments, urgent care centers, and outpatient pediatric or family medicine practices. An increased index of suspicion and discussion regarding higher level of care (transferring to pediatric tertiary care centers or to intensive care) continues to be recommended. Herein we outline a broad approach with a multidisciplinary team for those meeting the case definition and believe such an approach is crucial for successful outcomes.
Collapse
Key Words
- AP, approved
- ASO, anti-streptolysin O
- BNP, brain-natriuretic peptide
- CDC, Center for Disease Control
- COVID-19
- COVID-19, coronavirus disease 2019
- CRP, C-reactive protein
- CXCL10, C-X-C-motif chemokine ligand 10
- DCBLD2, Discoidin, CUB and LCCL domain-containing protein 2
- E, envelope protein
- E.U., European Union
- ECMO, extracorporeal membrane oxygenation
- EKG, electrocardiogram
- EM, emergency use
- FDA, US Food and Drug Authority
- Fever
- GI, gastrointestinal
- IL, interleukin
- IVIG, intravenous immunoglobulin G
- Inflammation
- KD, Kawasaki disease
- LDH, lactate dehydrogenase
- LFTs, liver function tests
- M, membrane protein
- MIS-C
- MIS-C, Multisystem Inflammatory Syndrome in Children
- Mpred, methylprednisolone
- NP, Nucleoprotein
- PCR, polymerase chain reaction
- PT, prothrombin time
- PTT, partial thromboplastin time
- Pediatric
- RBD, receptor binding domain
- SARS-CoV-2
- TE, thromboembolic events
- TNF, tumor necrosis factor
- TWEAK, TNF-like weak inducer of apoptosis
- U.S., United States of America
- VA, veno-arterial
- VLPs, virus-like particles
- VTE, venous thromboembolic events
Collapse
Affiliation(s)
- Teresa R Hennon
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Karl O A Yu
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Michelle D Penque
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Rabheh Abdul-Aziz
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Arthur C Chang
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Megan B McGreevy
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - John V Pastore
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Andrew J Prout
- Wayne State University School of Medicine, Detroit, MI, United States of America.,Children's Hospital of Michigan, Detroit, MI, United States of America
| | - Beverly A Schaefer
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Omar S Alibrahim
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Oscar G Gomez-Duarte
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| | - Mark D Hicar
- Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.,John R. Oishei Children's Hospital, Buffalo, NY, United States of America
| |
Collapse
|